In the Breast Cancer Linkage Consortium (BCLC), carriers of BRCA1 mutations showed less DCIS around the invasive lesion compared with controls (sporadic BC cases) (41 vs 56%) [3]. This evidence concerns the gene BRCA1 and breast carcinoma.